Dan Puckett - Dec 20, 2021 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Signature
/s/ Wade Estey, as attorney-in-fact for Dan Puckett
Stock symbol
SWAV
Transactions as of
Dec 20, 2021
Transactions value $
-$430,059
Form type
4
Date filed
12/21/2021, 04:12 PM
Previous filing
Nov 2, 2021
Next filing
Jan 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $25.5K +1.5K +3.28% $17.00* 47.3K Dec 20, 2021 Direct F1
transaction SWAV Common Stock Sale -$80.9K -486 -1.03% $166.47 46.8K Dec 20, 2021 Direct F2
transaction SWAV Common Stock Sale -$67.9K -406 -0.87% $167.24 46.4K Dec 20, 2021 Direct F3
transaction SWAV Common Stock Sale -$93.1K -552 -1.19% $168.61 45.8K Dec 20, 2021 Direct F4
transaction SWAV Common Stock Sale -$127K -750 -1.64% $169.46 45.1K Dec 20, 2021 Direct F5
transaction SWAV Common Stock Sale -$60.7K -356 -0.79% $170.61 44.7K Dec 20, 2021 Direct F6
transaction SWAV Common Stock Sale -$8.57K -50 -0.11% $171.34 44.7K Dec 20, 2021 Direct F7
transaction SWAV Common Stock Sale -$17.3K -100 -0.22% $172.83 44.6K Dec 20, 2021 Direct F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -1.5K -7.41% $0.00 18.7K Dec 20, 2021 Common Stock 1.5K $17.00 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $165.93 to $166.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $167.02 to $167.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $168.02 to $169.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $169.16 to $170.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $170.25 to $171.06. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The reported securities were sold at a price of $171.34.
F8 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $172.59 to $173.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F9 1/48th of the shares subject to the option shall vest monthly from 3/6/2019.